NCT02931396

Brief Summary

The purpose of this study is to demonstrate the efficacy of functional electrical stimulation (FES) for trans-tibial amputees. The investigators aim to demonstrate that providing three months of FES intervention will increase knee extension strength, increase volume of the residual limb and decrease chronic and phantom pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 25, 2016

Completed
9 months until next milestone

First Posted

Study publicly available on registry

October 13, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 3, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 3, 2018

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

March 21, 2019

Completed
Last Updated

December 2, 2024

Status Verified

November 1, 2024

Enrollment Period

2.4 years

First QC Date

January 25, 2016

Results QC Date

January 30, 2019

Last Update Submit

November 13, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in Knee Extension Isometric Strength (Peak Torque) Using the Biodex Measurement System

    Residual limb knee extension isometric strength was tested using a standardized Biodex protocol and custom attachment. The lever arm of the Biodex was positioned at 60 degrees of knee flexion, with the support cushion modified for the amputee and positioned at the mid-tibia. The participant was asked to extend their knee against the arm as hard as they could for five seconds.

    baseline and 12 weeks

  • Change in Residual Limb Volume Using 3-D Scanner

    3-D motion-tracking laser scanning system was used to determine residual limb volume in cm

    baseline and 12 weeks

  • Change in Residual Limb Pain Using Likert Scale Pain Questionnaire

    Scores were reported on a 0 to 10 scale with higher scores representing higher pain levels

    baseline and 12 weeks

Study Arms (2)

FES intervention

EXPERIMENTAL

Study participants who are randomized into the intervention group will be fitted with a portable commercially available surface FES device and instructed in its use by a study investigator. Participants will be directed to use the FES 30 minutes a day for the first week, one hour a day during the next week, 90 minutes a day during the third week, and then a minimum of 2 hours per day or 10 hours per week for the next three months at home.

Device: FES

Control

NO INTERVENTION

Participants will be asked to continue their activities of daily living as usual.

Interventions

FESDEVICE
FES intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women over 18 years of age.
  • Participants have a unilateral trans-tibial amputation with a minimum of a 4" residual limb. This length of amputation was chosen to provide for adequate surface area for the electrodes.
  • Participants must be a minimum of two years postoperative to insure proper healing of the limb has occurred.
  • Participants have chronic limb pain.
  • No prior experience in using TENS or FES.

You may not qualify if:

  • No cardiac conditions, such as hypertension, congestive heart failure, or a pacemaker.
  • People with severe diabetes who have insensate skin and or neuropathy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh

Pittsburgh, Pennsylvania, 15206, United States

Location

Results Point of Contact

Title
Alicia Koontz
Organization
University of Pittsburgh

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 25, 2016

First Posted

October 13, 2016

Study Start

September 1, 2015

Primary Completion

February 3, 2018

Study Completion

February 3, 2018

Last Updated

December 2, 2024

Results First Posted

March 21, 2019

Record last verified: 2024-11

Locations